RE:New here
15$ US target by HC Wainwright has existed since FEB of 2021. Target has never been downgraded. They value Breast cancer treatments at 1.6 Billion US. $ 8.50 CDN target by Douglas Loe is probably most detailed. His 2030 earnings model predictsearnings of over 6$ per share which at 20x earnings gives us a potential future value of over 120$ a share. So why is stock price so low? Oncolytics has a bit history of a troubled history and traders have made a lot of money buying and selling stock and shorting. Buying stock then selling after news. No big mystery there. It looks like things are about to change towards end of year or into 2023 Initial Pancreatic Cancer data on 3 patients shrunk tumors about 50% in 16 weeks. 10 year survival for Pancreatic is less than 5% with no real treatment options. Analysts want more data before adding Pancreatic Cancer to their price model but could be a game changer for the stock and Pancreatic Cancer patients. I think this is an investment opportunity of a lifetime but consider me biased and have been accumulating stock. Big blocks of stock are hard to buy now at times and stock can move on smaller volumes. Welcome to the board. Cheers!!!!!!!!